Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary Diffuspheretm technology designed to optimize local, controlled drug ...

Q3 2025 Earnings Call Transcript November 12, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is ...

Obesity isn’t a moral failing; it’s what happens when humans evolved for scarcity encounter permanent abundance. When you ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...

Apparently, when someone has a pacemaker, there's a battery too, and they don't bother taking it out/off. They simply snip ...

PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business ...

Promarkerendo Test For Endometriosis Receives $0.5M Grant. Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, announced it has been awarded a $500 ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden Presen ...

You're rummaging through the pantry for a quick, satisfying bite—something portable, packed with flavor, and ready to go. You grab a pouch of ...